Skip to main content
Disease Markers logoLink to Disease Markers
. 2023 Dec 13;2023:9753953. doi: 10.1155/2023/9753953

Retracted: Analysis of LINC01314 and miR-96 Expression in Colorectal Cancer Patients via Tissue Microarray-Based Fluorescence In Situ Hybridization

Disease Markers 1,
PMCID: PMC10732843  PMID: 38125386

This article has been retracted by Hindawi, as publisher, following an investigation undertaken by the publisher [1]. This investigation has uncovered evidence of systematic manipulation of the publication and peer-review process. We cannot, therefore, vouch for the reliability or integrity of this article.

Please note that this notice is intended solely to alert readers that the peer-review process of this article has been compromised.

Wiley and Hindawi regret that the usual quality checks did not identify these issues before publication and have since put additional measures in place to safeguard research integrity.

We wish to credit our Research Integrity and Research Publishing teams and anonymous and named external researchers and research integrity experts for contributing to this investigation.

The corresponding author, as the representative of all authors, has been given the opportunity to register their agreement or disagreement to this retraction. We have kept a record of any response received.

References

  • 1.Zhang R., Zhang G., Li B., et al. Analysis of LINC01314 and miR-96 Expression in Colorectal Cancer Patients via Tissue Microarray-Based Fluorescence In Situ Hybridization. Disease Markers . 2022;2022:10. doi: 10.1155/2022/5378963.5378963 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Disease Markers are provided here courtesy of Wiley

RESOURCES